ImpediMed Limited (IPD.AX)
AUD 0.04
(-10.26%)
AUD 0.04
(-10.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -23.48 Million AUD | 46.93% |
| 2023 | -44.26 Million AUD | -9.13% |
| 2022 | -40.56 Million AUD | -111.17% |
| 2021 | -19.2 Million AUD | -2.21% |
| 2020 | -18.79 Million AUD | -65.86% |
| 2019 | -11.33 Million AUD | 63.85% |
| 2018 | -31.34 Million AUD | 42.89% |
| 2017 | -54.88 Million AUD | 33.27% |
| 2016 | -82.25 Million AUD | -152.45% |
| 2015 | -32.58 Million AUD | -201.35% |
| 2014 | -10.81 Million AUD | -47.79% |
| 2013 | -7.31 Million AUD | 49.7% |
| 2012 | -14.54 Million AUD | 18.88% |
| 2011 | -17.93 Million AUD | 4.57% |
| 2010 | -18.78 Million AUD | -183.24% |
| 2009 | -6.63 Million AUD | 21.23% |
| 2008 | -8.42 Million AUD | 45.64% |
| 2007 | -15.49 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -35.63 Million AUD | 0.0% |
| 2024 Q4 | -23.48 Million AUD | 0.0% |
| 2024 FY | -23.48 Million AUD | 46.93% |
| 2023 Q2 | -24.87 Million AUD | 0.0% |
| 2023 Q4 | -44.26 Million AUD | 0.0% |
| 2023 FY | -44.26 Million AUD | -9.13% |
| 2022 Q2 | -50.48 Million AUD | 0.0% |
| 2022 Q4 | -40.56 Million AUD | 0.0% |
| 2022 FY | -40.56 Million AUD | -111.17% |
| 2021 FY | -19.2 Million AUD | -2.21% |
| 2021 Q4 | -19.2 Million AUD | 0.0% |
| 2021 Q2 | -18.37 Million AUD | 0.0% |
| 2020 FY | -18.79 Million AUD | -65.86% |
| 2020 Q2 | -12.13 Million AUD | 0.0% |
| 2020 Q4 | -18.79 Million AUD | 0.0% |
| 2019 Q2 | -22.63 Million AUD | 0.0% |
| 2019 Q4 | -11.33 Million AUD | 0.0% |
| 2019 FY | -11.33 Million AUD | 63.85% |
| 2018 FY | -31.34 Million AUD | 42.89% |
| 2018 Q4 | -31.34 Million AUD | 0.0% |
| 2018 Q2 | -42.4 Million AUD | 0.0% |
| 2017 Q4 | -54.88 Million AUD | 0.0% |
| 2017 Q2 | -73.23 Million AUD | 0.0% |
| 2017 FY | -54.88 Million AUD | 33.27% |
| 2016 FY | -82.25 Million AUD | -152.45% |
| 2016 Q4 | -82.25 Million AUD | 0.0% |
| 2016 Q2 | -25.15 Million AUD | 0.0% |
| 2015 FY | -32.58 Million AUD | -201.35% |
| 2015 Q2 | -38.24 Million AUD | 0.0% |
| 2015 Q4 | -32.58 Million AUD | 0.0% |
| 2014 Q4 | -10.81 Million AUD | 0.0% |
| 2014 FY | -10.81 Million AUD | -47.79% |
| 2014 Q2 | -4.53 Million AUD | 0.0% |
| 2013 Q2 | -9.64 Million AUD | 0.0% |
| 2013 Q4 | -7.31 Million AUD | 0.0% |
| 2013 FY | -7.31 Million AUD | 49.7% |
| 2012 Q4 | -14.54 Million AUD | 0.0% |
| 2012 FY | -14.54 Million AUD | 18.88% |
| 2011 FY | -17.93 Million AUD | 4.57% |
| 2011 Q4 | -17.93 Million AUD | 0.0% |
| 2010 Q4 | -18.78 Million AUD | 0.0% |
| 2010 FY | -18.78 Million AUD | -183.24% |
| 2009 Q4 | -6.63 Million AUD | 0.0% |
| 2009 FY | -6.63 Million AUD | 21.23% |
| 2008 FY | -8.42 Million AUD | 45.64% |
| 2008 Q4 | -8.42 Million AUD | 0.0% |
| 2007 FY | -15.49 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 7.834% |
| Adherium Limited | -6.1 Million AUD | -284.792% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -526.85% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -551.871% |
| Anteris Technologies Ltd | -28.49 Million AUD | 17.58% |
| Control Bionics Limited | -19.02 Thousand AUD | -123383.335% |
| CardieX Limited | 2.74 Million AUD | 955.289% |
| Compumedics Limited | 5.08 Million AUD | 561.746% |
| Cochlear Limited | -269.9 Million AUD | 91.297% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 3462.335% |
| Cyclopharm Limited | -7.49 Million AUD | -213.223% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | -49.6% |
| Nova Eye Medical Limited | -2.8 Million AUD | -738.294% |
| HeraMED Limited | -799.34 Thousand AUD | -2838.52% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 262.185% |
| InhaleRx Limited | -155.54 Thousand AUD | -15001.193% |
| LBT Innovations Limited | -604 Thousand AUD | -3788.907% |
| Micro-X Limited | 826.99 Thousand AUD | 2940.269% |
| Neurotech International Limited | -2.11 Million AUD | -1012.97% |
| OncoSil Medical Limited | -4.43 Million AUD | -430.139% |
| PolyNovo Limited | -30.52 Million AUD | 23.055% |
| Respiri Limited | 413.68 Thousand AUD | 5777.937% |
| SomnoMed Limited | -15.16 Million AUD | -54.912% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -342.859% |
| Uscom Limited | -1.53 Million AUD | -1434.594% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -475.295% |